2014年国际转化诊疗学会议（2014 International Symposium for Translational Theranostics）_门票优惠

转化医学（Translational Medicine）是近两三年来国际现代医学健康领域出现的新概念，是发展现代医疗健康服务的重要方面。转化医学的典型含义是将基础医学研究的成果转化成为实际患者提供的真正诊断治疗手段，强调的是在基础研究与临床医疗之间建立更直接的联系，缩短“从实验台到病床旁”的过程。20世纪末，美国国立卫生研究院（National Institutes of Health，NIH）发现，每年的研究经费高达200多亿美元，然而，发明了那么多的新技术，积累了那么多新的知识，发表了那么多的高水平论文，人们的健康状况并没有得到显著改善。由此，NIH提出了转化医学的概念，旨在让基础知识向临床治疗转化，促进健康水平的提升。转化医学是一个致力于克服基础研究与临床和公共卫生应用严重失衡的医学发展的新模式，其核心是在从事基础医学发现的研究者和了解患者需求的医生、以及卫生工作者之间建立起有效的联系，特别集中在分子基础医学研究向最有效和最合适的疾病预防诊断、治疗和预防模式的转化。转化医学致力于弥补基础实验研发与临床和公共卫生应用之间的鸿沟，为开发新药品、研究新的治疗方法开辟出了一条具有革命性意义的新途径。

转化医学的意义及其价值已引起世界各国的高度重视并催生战略行动。美国已在近40所大学建立了转化医学中心，美国政府对转化医学的重视程度日渐增高，企业也加强了在转化医学方面的投入。在我国，转化医学尚处于起步和探索阶段，但发展很快，全国一些院校和科研单位都成立了转化医学研究中心，许多制药公司正在建立转化医学团队以增强基础研究和临床医学的沟通，这一切为我国转化医学的进一步发展打下了坚实的基础。2010年，转化医学已成为国家在生物医学领域里一个重大的政策，《中共中央关于制定国民经济和社会发展第十二个五年规划的建议》中指出：“以转化医学为核心，大力提升医学科技水平，强化医药卫生重点学科建设。”

2013年，深圳市发布了《深圳生命健康产业发展规划（2013-2020年）》，把生命信息、高端医疗、健康管理等列为重点发展领域。建立在基因组遗传学、组学芯片等系统生物学与技术基础上的转化医学，是生命信息、高端医疗等发展的重要基础。本次国际转化诊疗学峰会，正是基于这样的思考，在医疗诊断与治疗两个最基础也最关键的环节，研究、按寻、促进转化医疗的发展以及产业化的推进。本次会议，将从全球范围，为医学、生命科学、物理、化学等领域的研究者提供一个学术思想交流与碰撞的机会。组织者希望这次会议能以年会的形式在深圳持续下去，形成一个国际化转化医学不同领域研究者的对话机制，以促进深圳生命健康产业特别是高端医疗细分行业的快速发展。

Join us at the International Symposium for Translational Theranostics on 26-27 May 2014. This event is organised by Graduate School at Shenzhen, Tsinghua University.

2014 International Symposium for Translational Theranostics is to provide a platform for scientists in medicine, life science and other health-related fields to share their emerging research in translational medicine for disease diagnostic and treatment, and outlook the future of translational medicine.

Theranostics, as a key part of predictive medicine, includes a wide range of subjects, including personalized medicine, pharmacogenomics, and molecular imaging to develop efficient new targeted therapies with adequate benefit/risk to patients and a better molecular understanding of how to optimize drug selection. Translational theranostics is the leading direction changing the setup of the current medical reseach and implementation.

The symposium will bring you the new vision in translational medicine, novel scientific discovery on biomarker research, the cutting edge of technology for disease diagnostics and therapy. For more information, please click here

We hope the two-day symposium will provide participants with an up to date review of the most recent, clinically-relevant developments in theranostics.

May 25, 2014
14:00 – 19:00 a.m.	Registration and breakfast

May 26, 2014
7:00 – 8:15 a.m.	Registration and breakfast
8:15 – 8:30 a.m.	Opening remark
Session 1 New Vision for Disease Biomarkers Chair: Christos Patriotis, Ph.D. Program Director, Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, NIH, USA.
8:30 – 9:00 a.m.	Daniel Chan, Ph.D., DABCC, FACB Professor of Pathology, Oncology, Radiology & Urology Director, Clinical Chemistry Division & Center for Biomarker Discovery and Translation Co-Director, Pathology Core Laboratories, Department of Pathology Johns Hopkins Medical Institutions “Translation of Cancer Biomarkers into Clinical Practice: The 4Bs, 4Gs & 4Ps”
9:00 – 9:30 a.m.	Joshua Labare, M.D., Ph.D. Virginia G. Piper Center for Personalized Diagnostics, Biodesign Institute, Arizona State University “High Throughput Cell-Based Studies and Protein Microarrays for Biomarker and Target Discovery”
9:30 – 10:00 a.m.	Christos Patriotis, Ph.D. Program Director, Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, NIH, USA. “Understanding the Natural History of Cancer is Essential for the Development of Effective Early Diagnostics that can Impact Survival and Mortality Rates”
10:00 – 10:15 a.m.	Coffee break
Session 2 Clinical Practice Chair: Weihong Tan, Ph.D. V. T. and Louise Jackson Professor of Chemistry Department of Chemistry, Department of Physiology and Functional Genomics Center for Research at Bio/nano Interface, Moffitt Cancer Center and Shands Cancer Center, University of Florida
10:15 -10:45 a.m.	Christian F Singer, MD, MPH Professor of Clinical-Translational Gynecological Oncology, Medical University of Vienna Vienna, Austria “Serial tumor assessments as a theragnostic tool in neoadjuvant Window Trials”
10:45 – 11:15 a.m.	Xifeng Wu, M.D., Ph.D. Professor and Chair Department of Epidemiology Betty B. Marcus Chair in Cancer Prevention Director, Center for Translational and Public Health Genomics The University of Texas MD Anderson Cancer Center, USA “Extending the Reach of Integrative Population Science: Clinical and Population Applications”
11:15 – 11:45 a.m.	John Cooks, MD, Ph.D. Chair, Department of Cardiovascular Sciences Director, Center for Cardiovascular Regeneration Houston Methodist Research Institute “How Nuclear Reprogramming will change the practice of Medicine”
12:00 – 1:30 p.m.	Lunch
Session 3Nanomedicine in Theranostics 1 Chair: Xiaoyuan (Shawn) Chen, Ph.D. Senior Investigator and Chief Laboratory of Molecular Imaging and Nanomedicine National Institute of Biomedical Imaging and Bioengineering National Institutes of Health
1:30 – 2:15 p.m.	Wolfgang J. Parak, Ph.D. Professor, FachbereichPhysik, PhilippsUniversität Marburg, Marburg, Germany CIC Biomagune, San Sebastian, Spain Degradation of nanoparticles in biological environments
2:15 – 2:45 p.m.	Jwa-Min Nam, Ph.D. Associate Professor Department of Chemistry, Seoul National University DNA-Engineered Plasmonic Nanostructure-Based Biosensing Strategies
2:45 – 3:15 p.m.	Xiaoyuan (Shawn) Chen, Ph.D. Senior Investigator and Chief Laboratory of Molecular Imaging and Nanomedicine National Institute of Biomedical Imaging and Bioengineering National Institutes of Health A Versatile Nanoplatform for Systemic Delivery of RNAis
3:15 – 3:30 p.m.	Coffee break
Session 4 Regulation in Clinical Translation Chair: Tong Sun MBA Director, Central Operations Houston Methodist Research Institute
3:30 – 4:15 p.m.	Anil K. Patri, Ph.D. Deputy Director, Nanotechnology Characterization Laboratory Frederick National Laboratory for Cancer Research Leidos Biomedical Research, Inc. Nanomedicines: Design Principles for Biomedical Applications
4:15 – 4:45 p.m.	Edward A. Jones, MBA Chief Operating Officer Houston Methodist Research Institute “Clinical Translation: Research Operations and Management for the patient”
4:45 – 5:15 p.m.	Brian J. Dunkin M.D., F.A.C.S. Associate Member The Methodist Hospital Research Institute Head, Section of Endoscopic Surgery, Department of Surgery Medical Director, Methodist Institute for Technology, Innovation and Education (MITIE), The Methodist Hospital Title: TBA
May 27, 2014
7:00 – 8:30 a.m.	Breakfast
Session 1 New Molecular Targets for Theranostics Chair: Yigong Shi Ph.D. Member of Chinese National Academy of Sciences Director of Life Science College Tsinghua University
8:30 – 9:00 a.m.	Nancy Jenkins, Ph.D. Member of the US National Academy of Sciences Senior Member, The Methodist Hospital Research Institute Co-Director, The Methodist Cancer Research Program Dean of Genetics, The Methodist Academy Transposon mutagenesis identifies genes driving HCC in a chronic hepatitis B mouse model
9:00 – 9:30 a.m.	Neal G. Copeland, Ph.D. Member of the US National Academy of Sciences Senior Member,The Methodist Hospital Research Institute Director, The Methodist Cancer Research Program Dean of Cancer Biology, The Methodist Academy Harnessing Transposons for Cancer Gene Discovery in the Gastrointestinal Tract
9:30 – 10:00 a.m.	Li Ma, Ph.D. Assistant Professor The University of Texas MD Anderson Cancer Center Novel determinants and therapeutic targets in breast cancer
10:00 – 10:15 a.m.	Coffee break
Session 2Advanced Imaging Technologies Chair: HosseinJadvar, MD, PhD, MPH, MBA Associate Professor of Radiology and Vice Chair of Research University of Southern California, Los Angeles, California, USA Vice President-Elect, Society of Nuclear Medicine and Molecular Imaging
10:15 -10:45 a.m.	Peter Herscovitch, MD President-Elect, Society of Nuclear Medicine and Molecular Imaging (SNMMI) “Amyloid Imaging in the Developments of Anti-Alzheimer Disease Therapeutics”
10:45 – 11:15 a.m.	MingyuanGao Professor Institute of Chemistry, Chinese Academy of Sciences, China Functional nanoparticles for tumor imaging
11:15 – 11:45 a.m.	HosseinJadvar, MD, PhD, MPH, MBA Associate Professor of Radiology and Vice Chair of Research University of Southern California, Los Angeles, California, USA Vice President-Elect, Society of Nuclear Medicine and Molecular Imaging “Clinical and Translational Molecular Imaging and Therapy of Prostate Cancer”
12:00 – 1:30 p.m.	Lunch
Session 3 Nanomedicine in Theranostics 2 Chair: Weihong Tan, Ph.D. V. T. and Louise Jackson Professor of Chemistry Department of Chemistry, Department of Physiology and Functional Genomics Center for Research at Bio/nano Interface, Moffitt Cancer Center and Shands Cancer Center, University of Florida
1:30 – 2:15 p.m.	Feng Si-Shen, Ph.D. Professor Department of Chemical &Biomolecular Engineering, National University of Singapore Advances in Nanomedicine
2:15 – 2:45 p.m.	Weihong Tan, Ph.D. V. T. and Louise Jackson Professor of Chemistry Department of Chemistry, Department of Physiology and Functional Genomics Center for Research at Bio/nano Interface, Moffitt Cancer Center and Shands Cancer Center, University of Florida The foundation of molecular medicine: A chemical biology approach
2:45 – 3:15 p.m.	GuangjunNie Professor, National Center for Nanoscience and Technology, China Regulation of tumor microenvironment via nano-drug systems for tumor diagnosis and therapy
3:15 – 3:30 p.m.	Coffee break
Session 4 Clinical Chemistry - 2 Chair: Tony Hu, Ph.D. Assistant Professor Department of Nanomedicine The Methodist Hospital Research Institute
3:30 – 4:15 p.m.	XiaogangQu Professor Laboratory of Chemical Biology, Division of Biological Inorganic Chemistry, State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, University of Chinese Academy of Sciences, Chinese Academy of Sciences, China Chemical Controlled Biomolecular Recognitions and Their Applications in Disease Diagnosis and Treatment
4:15 – 4:45 p.m.	Tony Hu, Ph.D. Assistant Professor Department of Nanomedicine The Methodist Hospital Research Institute Assistant Professor Department of Cell and Developmental Biology Weill Cornell Medical College of Cornell University Circulating proteolytic products of tumor-resident enzyme as potential biomarkers for cancer early detection
4:45 – 5:15 p.m.	HongxiXu, Ph.D Professor, School of Pharmacy, Shanghai University of Traditional Chinese Medicine Use of compounds from medicinal plants for targeted anticancer therapy

2014年4月20日前：RMB2000元/USD350
2014年4月20日-5月15日：RMB2500元/USD400

1、免费活动如何报名参加？
请通过文章中的联系方式报名参加。

2、价格显示为收费的活动具体费用是多少？我要如何报名？
你可以在网站上留言或电话(400-003-3879)咨询，我们会尽快联系你。

3、活动具体地址在哪里？
1、活动具体地址待报名后告知。
2、报名前可咨询“活动家”客服，服务热线 400-003-3879

4、活动截止报名时间是什么时候？
尽早报名，早报早优惠。

5、怎么提交论文？论文参会如何收费？
亲，您好！我们暂不接受论文提交或论文参会。

6、活动发票如何领取？
亲，您好！请您在下单时，在备注框内填写好发票抬头，发票寄送地址或其它信息，以便您能即时有效的收到发票。

会议标签：

医学技术

活动家提供2014年国际转化诊疗学会议（2014 International Symposium for Translational Theranostics）官网最新门票优惠(更新于:2014年10月10日)。2014年国际转化诊疗学会议（2014 International Symposium for Translational Theranostics）将于2014年05月26日在深圳召开，优惠票在线报名截止2014年05月26日。一键查询2014年国际转化诊疗学会议（2014 International Symposium for Translational Theranostics）会议通知及邀请函下载，包含开会时间地点、嘉宾演讲主题、日程、价格等会议信息，报名2014年国际转化诊疗学会议（2014 International Symposium for Translational Theranostics），轻松快捷。

2014年国际转化诊疗学会议（2014 International Symposium for Translational Theranostics）

2026年第十届眼科学教育大会

第二十六届国际眼科学学术会议、第二十六届国际视光学学术会议 COOC2026